LENT Score Calculator – Malignant Pleural Effusion Survival Prediction
LENT Score Calculator
Enter the patient's findings at presentation with malignant pleural effusion.
This score estimates prognosis at presentation with malignant pleural effusion; it does not provide an individualized survival prediction.
About the LENT Score
The LENT score is a prognostic tool developed for patients presenting with malignant pleural effusion (MPE). It combines pleural fluid lactate dehydrogenase (LDH), ECOG performance status, neutrophil-to-lymphocyte ratio (NLR), and tumour type.
Scoring Criteria
| Variable | Criterion | Points |
|---|---|---|
| Pleural fluid LDH | <1500 / ≥1500 IU/L | 0 / 1 |
| ECOG PS | 0 / 1 / 2 / 3–4 | 0 / 1 / 2 / 3 |
| Blood NLR | <9 / ≥9 | 0 / 1 |
| Tumour type | Lower / Moderate / Higher risk group | 0 / 1 / 2 |
Prognostic Groups
| Score | Risk group | Median survival (original cohort) |
|---|---|---|
| 0–1 | Low | 319 days (IQR 228–549) |
| 2–4 | Moderate | 130 days (IQR 47–467) |
| 5–7 | High | 44 days (IQR 22–77) |
Clinical Use
Use the score as an adjunct to clinical assessment and shared decision-making. Consider the patient's overall condition, cancer subtype and stage, available anticancer treatment, comorbidities, goals of care, and subsequent clinical course.
References
Important Notes
- The score was developed for prognostic stratification at presentation with MPE.
- Median survival values describe the original study cohorts, not an individual patient's expected lifespan.
- Patients with incomplete or unavailable components should not be assigned an assumed score.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.